FDA issues warning on use of azithromycin

03/13/2013 | Los Angeles Times (tiered subscription model) · Reuters

The FDA issued a warning that the antibiotic azithromycin, marketed as Zithromax or Zmax, could cause potentially fatal irregular heart rhythm in some patients. The agency said at-risk patients include those with a slower-than-normal heartbeat, with potassium or magnesium deficiencies, and those using medications to treat existing heart arrhythmia.

View Full Article in:

Los Angeles Times (tiered subscription model) · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY